External Quality Assurance
Molecular Genetics
Scheme Provider | Scheme |
---|---|
UKNEQAS for Blood Coagulation | Thrombophilia Genotyping – Factor V Leiden Mutation and Prothrombin Mutation 20210A |
UKNEQAS for Molecular Genetics | Molecular testing on bloodspots – Cystic Fibrosis (CF) |
UKNEQAS for Molecular Genetics | Molecular testing on bloodspots – Medium Chain acyl-CoA dehydrogenase deficiency (MCADD) |
UKNEQAS for Molecular Genetics | Familial Hypercholesterolaemia (FH) |
UKNEQAS for Molecular Genetics | Fragile X |
UKNEQAS for Molecular Genetics | Microsatellite Instability (MSI) |
UKNEQAS for Molecular Genetics | Pathogenicity of sequence variants pilot scheme |
UKNEQAS for Molecular Genetics | Charcot-Marie-Tooth neuropathy type 1A & hereditary neuropathy with liability to pressure palsies |
UKNEQAS for Molecular Genetics | Myotonic Dystrophy Type 1 Interpretation |
UKNEQAS for Molecular Genetics | Medium Chain acyl-CoA dehydrogenase deficiency (MCADD) full scheme |
UKNEQAS for Molecular Genetics | Cystic Fibrosis (CF) full scheme |
UKNEQAS for Molecular Genetics | Huntington Disease |
UKNEQAS for Molecular Genetics | Spinal muscular atrophy |
EMQN | AZF testing (Y chromosome microdeletion analysis) |
EMQN | BRCA testing (BRCA1 and BRCA2 analysis) |
EMQN | DFNB1 testing (Sensorineural deafness) |
EMQN | PKU (PAH gene analysis) |
EMQN | FH (familial hypercholesterolaemia) |
EMQN | HFE (haemochromatosis) |
EMQN | Sanger DNA sequencing |
Cytogenetics
Scheme Provider | Scheme |
---|---|
CEQAS | Chorionic villus Sampling (CVS) |
CEQAS | Blood/FISH |
CEQAS | Amniotic Fluid |
CEQAS | Products of conception/fetal tissue analysis |
Sample swap | Solid tissue for telomere analysis |
Molecular Cytogenetics
Scheme Provider | Scheme |
---|---|
UKNEQAS for Molecular Genetics | Maternal Cell Contamination and Sexing |
CEQAS | Microarray |
CEQAS | Molecular Rapid Aneuploidy (MRA) |
Oncology Genetics
Scheme Provider | Scheme |
---|---|
EuroMRD | Ig/TCR based minimal residual disease analysis |
EuroMRD | MLL based minimal residual disease analysis |
CEQAS | Lymphoproliferative disease (LPD) |
CEQAS | Myeloid Leukaemia (AML, MDS, CML) |
CEQAS | Tumour |
CEQAS | B or T Lymphoblastic leukaemia |
UKNEQAS for Leucocyte Immunophenotyping | Hairy Cell Leukaemia BRAF mutation V600E pilot scheme |
UKNEQAS for Leucocyte Immunophenotyping | BCR/ABL Quantitation |
UKNEQAS for Leucocyte Immunophenotyping | IGH/TCR Clonality |
CEQAS | Adult Molecular Neuropathology pilot scheme |
UKNEQAS for Molecular Pathology | Melanoma (BRAF gene) |
UKNEQAS for Molecular Pathology | Non-small cell lung cancer (EGFR gene and ALK gene rearrangement) |
UKNEQAS for Molecular Pathology | Colorectal cancer (KRAS) |
UKNEQAS for Leucocyte Immunophenotyping | Paediatric Acute Leukaemia Translocation (PALT) pilot scheme |
UKNEQAS for Leucocyte Immunophenotyping | FMS-Like Tyrosine-3 (FLT3 gene) status |
UKNEQAS for Leucocyte Immunophenotyping | JAK2 V617F status |
UKNEQAS for Leucocyte Immunophenotyping | Nucleophosmin testing (NPM1) |
UKNEQAS for Molecular Genetics | Breast Cancer (BRCA1 and BRCA2 genes) full scheme |
UKNEQAS for Leucocyte Immunophenotyping | BCR-ABL Kinase domain mutation status pilot scheme |
UKNEQAS for Leucocyte Immunophenotyping | KIT D816V mutation statuspilot scheme |
UKNEQAS for Leucocyte Immunophenotyping | BCR-ABL1 and AML translocations |
Sample swap | MPL Exon 10 gene testing |
Antimicrobial Reference Laboratory
Scheme Provider | Scheme |
---|---|
UKNEQAS TDM | Anti bacterial panel (vancomycin, teicoplanin, tobramycin, gentamicin, amikacin) |
UKNEQAS TDM | Anti fungal panel (itraconazole, posaconazole, Flucytosine, voriconazole) |
Instand eV | TDM 197 (Amikacin, Gentamicin, Tobramycin, Vancomycin) |
Instand eV | TDM 193 (Teicoplanin) |
Instand eV | TDM 198 (Chloramphenicol, Flucoazole, Posaconazole, Voriconazole, Flucytosine) |
Instand eV | TDM 602 (itraconazole) |
SKML | Anti-TB (Linezolid, Rifampicin, Ethambutol, Levofloxacin, Moxifloacin, Rifabutin) |
SKML | Antiviral drugs (Aciclovir, Ganciclovir) |
Bacteriology
Scheme Provider | Scheme |
---|---|
Lab Quality | CSF |
Lab Quality | Gram Staining |
Lab Quality | H.pylori Faecal Antigen detection |
Lab Quality | Urine cell count |
Lab Quality | Blood cultures |
Lab Quality | Urine culture |
Lab Quality | Multi-drug resistant GNBs |
LGC | Gram stain – Bacterial vaginitis |
LGC | Crypto/Giardia Faecal Antigen detection |
QCMD | MALDI-Tof Identification of bacterial isolates |
UKNEQAS - Microbiology | AAFB microscopy |
UKNEQAS - Microbiology | Antimicrobial Sensitivities |
UKNEQAS - Microbiology | C.difficile toxin |
UKNEQAS - Microbiology | Faecal Parasites |
UKNEQAS - Microbiology | Genital Pathogens |
UKNEQAS - Microbiology | General Bacteriology |
UKNEQAS - Microbiology | MRSA Screening |
UKNEQAS - Microbiology | Mycobacterium Culture |
UKNEQAS - Microbiology | Mycology ID (Routine dermatology) |
UKNEQAS - Microbiology | Mycology sensitivities |
UKNEQAS - Microbiology | Mycobacterium molecular procedures |
UKNEQAS - Microbiology | Urinary antigen detection (Legionella sp, Strep. pneumo) |
Inter-laboratory exchange | Crypto/Giardia screening |
Mycology Reference Laboratory
Scheme Provider | Scheme |
---|---|
UKNEQAS - Immunology | Aspergillus Fumigatus |
UKNEQAS - Immunology | Avian Precipitins - Pigeon |
UKNEQAS - Immunology | Avian Precipitins - Budgerigar |
UKNEQAS - Immunology | M.faeni |
UKNEQAS - Immunology | Candida albicans |
UKNEQAS - Immunology | Fungal and related antigens |
UKNEQAS | Fungal Biomarkers |
Instand eV | Dematophytes, Yeasts, Mould fungus (491) |
Instand eV | Yeasts (490) |
Instand eV | Cryptococcal antigen (481) |
Instand eV | Candida Antigen & Antibody (480) |
QCMD | Candida PCR |
QCMD | Aspergillus PCR |
Inter-laboratory exchange | Beta Glucan |
Inter-laboratory exchange | Aspergillus antigen |
Lab Quality | Fungal Culture |
Virology
Scheme Provider | Scheme |
---|---|
CSCQ | Lyme borreliosis |
Instand eV | Chlamydia serology distribution |
Instand eV | Q fever serology distribution |
Instand eV | SARS-CoV-2 Molecular detection |
Instand eV | Streptococcal antibodies detection |
Instand eV | SARS-CoV-2 genome detection |
Instand eV | Influenza typing including avian |
Lab Quality | B burgdorferi antibodies |
Lab Quality | H pylori antibodies distribution |
Lab Quality | Herpes Simplex Antibodies |
Lab Quality | M. pneumoniae serology distribution |
Lab Quality | Measles Abs distribution |
Lab Quality | Mumps IgG & IgM antibody |
Lab Quality | Parvovirus B19 Abs distribution |
Lab Quality | Rubella Abs distribution |
Lab Quality | Hepatitis E antibodies |
Lab Quality | H pylori antibodies distribution |
Lab Quality | Pertussis Serology |
Lab Quality | CMV Serology (Inc Avidity) |
Lab Quality | SARS-CoV-NA detection |
Lab Quality | SARS-CoV Serology |
Lab Quality | STD (TV & MG) NAAT detection |
QCMD | Adenovirus DNA detection |
QCMD | B. pertussis DNA detection |
QCMD | BK DNA detection |
QCMD | C. trachomatis DNA detection |
QCMD | CMV DNA (whole blood) detection |
QCMD | CMV DNA detection |
QCMD | EBV DNA (whole blood) detection |
QCMD | EBV DNA detection |
QCMD | Enterovirus RNA detection |
QCMD | HBV DNA quantification |
QCMD | HCV Genotype identification |
QCMD | HCV RNA quantification |
QCMD | HHV6 DNA detection |
QCMD | HIV RNA quantification |
QCMD | HSV DNA detection |
QCMD | Influenza A & B RNA detection |
QCMD | Influenza Haemagglutinin Typing |
QCMD | Measles RNA detection |
QCMD | Metapneumonvirus RNA detection |
QCMD | N. gonorrhoeae detection |
QCMD | Norovirus RNA detection |
QCMD | Parainfluenza RNA detection |
QCMD | Parvovirus B19 DNA detection |
QCMD | Rhinovirus RNA detection |
QCMD | RSV RNA detection |
QCMD | VZV DNA detection |
QCMD | Viral Gastroenteritis |
QCMD | SARS-COV-2 RNA detection |
RCPAQAP | Chlamydia Genus serology |
RCPAQAP | Q fever serology |
UKNEQAS - Microbiology | Anti-HBs serology |
UKNEQAS - Microbiology | Blood borne viruses serology |
UKNEQAS - Microbiology | Blood donor screen serology |
UKNEQAS - Microbiology | C. trachomatis & N. gonorrhoeae NAAT detection |
UKNEQAS - Microbiology | CMV DNA quantification |
UKNEQAS - Microbiology | Diagnostic serology hepatitis |
UKNEQAS - Microbiology | EBV DNA Quantification |
UKNEQAS - Microbiology | HBV DNA quantification |
UKNEQAS - Microbiology | Hepatitis B serology |
UKNEQAS - Microbiology | Hepatitis C RNA detection |
UKNEQAS - Microbiology | Hepatitis C serology |
UKNEQAS - Microbiology | Hepatitis E serology |
UKNEQAS - Microbiology | HIV RNA quantification |
UKNEQAS - Microbiology | HIV serology |
UKNEQAS - Microbiology | Immunity screen |
UKNEQAS - Microbiology | Measles IgG & Mumps IgG serology |
UKNEQAS - Microbiology | Molecular detection of respiratory viruses |
UKNEQAS - Microbiology | Multiplex detection of respiratory viruses |
UKNEQAS - Microbiology | Parvo B19 and Rubella serology |
UKNEQAS - Microbiology | Rubella IgG serology |
UKNEQAS - Microbiology | Syphilis serology |
UKNEQAS - Microbiology | Toxoplasma serology |
UKNEQAS - Microbiology | Viral gastroenteritis - Molecular detection |
UKNEQAS - Microbiology | Viruses in CSF (molecular) distribution |
UKNEQAS - Microbiology | SARS-COV-2 (molecular detection) |
WEQAS | SARS-COV-2 Antibodies |
Clinical Biochemistry
Scheme Provider | Scheme |
---|---|
UKNEQAS - general Chemistry assays | Sodium, potassium, chloride, bicarbonate, urea, urate, glucose. Lactate, calcium, adjusted calcium, phosphate, bilirubin, iron, transferrin, total protein, albumin, magnesium, AST, ALT, LD, CK, ALP, amylase, GGT, lipase, AFP (Tumour) Albumin, AMH, B12, Ca-125 .Ca15-3, Ca19-9, CEA, Bililrubin, Cholesterol Creatinine, CRP, Ferritin, Folate, Glucose, Haem pigments, HCG, Icterus, Lactate, Lipaemia, Lipase, Macroprolactin, Parathyroid hormone, PSA, SHBG, Total Bilirubin, Total Protein, Triglycerides, Urea, Vitamin D |
UKNEQAS | Erythropoetin (EPO) General Immune Serology (TPO) Intrinsic Factor Antibodies (IFAB) Lipids Paracetamol, salicylate, ethanol & TDM Peptide hormones FSH, LH, Prolactin, macroprolactin, AMH Thyroid |
UKNEQAS | Fluids (total protein, albumin, glucose, amylase, creatinine, urea, lactate, total cholesterol, triglyceride) |
UKNEQAS | Urine Chemistry (electrolytes, osmolality, protein, calcium, albumin) |
UKNEQAS | CSF Spectroscopy scheme |
German Scheme RfB | Blood spot 17OH progesterone |
ERNDIM | Acylcarnitines in Serum (carnitine) ACDB scheme (Acylcarnitine’s in dried blood spots, includes interpretation) |
ERNDIM | DPT Scheme (Diagnosis Proficiency Testing) |
ERNDIM | Special assays in urine (GTL) |
ERNDIM | QLOU scheme (Qualitative Organic Acids in urine) |
ERNDIM | Quantitative amino acids |
ERNDIM | Quantitative methyl malonic acid (ORGS) (urine) |
ERNDIM | Quantitative special serum assays (hydroxybutyrate, phytanate, VLCFA, pristanate, 7-dehydrocholesterol, free carnitine, NEFA ) |
ERNDIM | CN, PHE and TYR in dried blood spots |
Centre for Disease Control (USA) | CDC DBS galactose-1-phosphate uridyltransferase (GALT) |
UKNEQAS | Newborn screening includes following blood spot markers (TSH, IRT on the GSP) |
UKNEQAS | Newborn screening for markers Phe, Tyr, C8 , C10, C8/10 |
UKNEQAS | Sickle Cell |
LGC International Proficiency Scheme | Antipsychotics/SSRI/TCA Carboxyhaemoglobin Case studies for toxicology Ethanol (blood, urine, serum) Paracetamol Tacrolimus, Cyclosporin and Sirolimus Toxicology Serum Toxic Alcohols |
UKNEQAS | Cholinesterase inhibitor and activity |
RIQAS | Urine drugs of abuse |
Equalis (Swedish) | Iohexol |
Immunology
Scheme Provider | Scheme |
---|---|
UK NEQAS | Paraneoplastic Antibodies |
UK NEQAS | B2Microglobulin |
UK NEQAS | C1 Inhibitor and Functional Complement |
UK NEQAS | Monoclonal Protein Identification |
UK NEQAS | General Autoimmune Serology |
UK NEQAS | Nuclear and Related Antibodies (Hep2) |
UK NEQAS | Nuclear and Related Antibodies (rodent tissue ANA and critidia) |
UK NEQAS | Bullous Dermatosis |
UK NEQAS | IgG Subclasses |
UK NEQAS | Total IgE |
UK NEQAS | Allergen Specific IgE |
UK NEQAS | ANCA/GBM Antibodies |
UK NEQAS | Coeliac Disease Antibodies |
UK NEQAS | Diabetic Markers |
UK NEQAS | Specific Proteins Dist |
UK NEQAS | CSF for Oligonclonal Bands |
UK NEQAS | Faecal Markers of Bowel Inflammation |
UK NEQAS | CSF for Beta 2 Transferrin |
UK NEQAS | Alpha 1 Antitrypsin Phenotyping |
UK NEQAS | ACHR Antibodies |
UK NEQAS | Phospholipid Antibodies |
UK NEQAS | Mast Cell Tryptase |
UK NEQAS | Fungal Related Antigens |
UK NEQAS | Immune Monitoring CD4 Counts |
UK NEQAS | Leukaemia Immunophenotyping |
UK NEQAS | Leukaemia Interpretation Scheme |
UK NEQAS | MRD ALL |
UK NEQAS | Interferon Gamma Release Assay - TB |
UK NEQAS | PNH |
UK NEQAS | Allergen Component Testing |
UK NEQAS | ABO Titration |
UK NEQAS | Scheme 1B HLA-B27 Testing |
UK NEQAS | Scheme 2B Crossmatching by Flow Cytometry - B cell |
UK NEQAS | Scheme 2B Crossmatching by Flow Cytometry - T cell |
UK NEQAS | Scheme 3 HLA Antibody Specificity Analysis |
UK NEQAS | Scheme 4A1 HLA DNA Typing 1st Field Only |
UK NEQAS | Scheme 6 Antibody Detection |
UK NEQAS | Scheme 7 HLA-B57:01 Typing |
UK NEQAS | Scheme 8 'Disease' Typing HLA-DR/DQ/DP only |
UK NEQAS | Cryoglobulin (pilot) |
UK NEQAS | Myositis Associated Antibody |
UK NEQAS | Faecal Pancreatic Elastase |
UK NEQAS | MRD CLL (pilot) |
UK NEQAS | MRD AML (pilot) |
UK NEQAS | Educational Crossmatch Scheme |
WEQAS | FOB/FIT (pilot) |
UK NEQAS | Phospholipase A2 Receptor Antibody |
UK NEQAS | CSF Immunophenotyping (pilot) |
UK NEQAS | Alkaline Phsphatase (ALP) Isoenzymes (pilot) |
Cellular Pathology
Scheme Provider | Scheme |
---|---|
UK NEQAS | UK NEQAS for Cellular Pathology Tecnique - General |
UK NEQAS | UK NEQAS for Cellular Pathology Tecnique - Cytology |
UK NEQAS | NEQAS for Immunohistochemistry - General |
UK NEQAS | NEQAS for Immunohistochemistry - Lymphoma |
UK NEQAS | NEQAS for Immunohistochemistry - Breast |
UK NEQAS | NEQAS for Immunohistochemistry - HER2 |
SW Regional EQA | SW Regional EQA Papanicolaou in Cervical Cytology |
SW Regional EQA | SW Region Cervical Cytology scheme |
National scheme | HPV |
National Gynaecological Histology Scheme | Interpretive Schemes pathologists practising in speciality |
Regional Histopathology EQA Scheme | Interpretive Schemes pathologists practising in speciality |
GI Pathology EQA Scheme | Interpretive Schemes pathologists practising in speciality |
Bowel Cancer Screening | Interpretive Schemes pathologists practising in speciality |
National Uropathology EQA Scheme | Interpretive Schemes pathologists practising in speciality |
National Dermatology EQA Scheme | Interpretive Schemes pathologists practising in speciality |
National Prostate Core EQA Scheme | Interpretive Schemes pathologists practising in speciality |
National Renal Pathology EQA Scheme | Interpretive Schemes pathologists practising in speciality |
National Renal Transplant EQA Scheme | Interpretive Schemes pathologists practising in speciality |
Regional Cervical Cytopathology EQA Scheme | Interpretive Schemes pathologists practising in speciality |
Haematology
Scheme Provider | Scheme |
---|---|
UK NEQAS | Full Blood Count |
UK NEQAS | G6PD |
UK NEQAS | Auto WBC Differential |
UK NEQAS | Retic Count |
UK NEQAS | Haemoglobinopathy |
UK NEQAS | Sickle Screen |
UK NEQAS | Cytochemistry, FE Stain |
UK NEQAS | Blood Film Morphology/Parasitology |
UK NEQAS | Manual WBC Differential |
UK NEQAS | Rapid Malaria Antigen Test |
UK NEQAS | nRBCc |
UK NEQAS | Plasma Viscosity |
UK NEQAS | Ferritin |
UK NEQAS | Intrinsic Factor Antibodies |
UK NEQAS | B12/Folate |
UK NEQAS | Erythropoietin |
UK NEQAS | INR/PT |
UK NEQAS | APTT |
UK NEQAS | Thrombin Time |
UK NEQAS | Heparin Dosage Assessment |
UK NEQAS | Heparin Assay |
UK NEQAS | Fibrinogen |
UK NEQAS | D-Dimer |
UK NEQAS | Coagulation Factor Assays: VIII, IX II,V,VII,XI,XII,FXIII |
UK NEQAS | VWF RiCof VWF antigen |
UK NEQAS | Antithrombin Activity |
UK NEQAS | Protein C Activity |
UK NEQAS | Free Protein S Antigen |
UK NEQAS | Activated Protein C resistance |
UK NEQAS | Lupus Antigoagulant |
UK NEQAS | Blood Transfusion |
UK NEQAS | BTLP (Blood Transfusion) |
UK NEQAS | FMH (Blood Transfusion) Acid Elution |
ECAT (Dutch EQA Scheme) | Anti-Xa tests |
SMTN Research
Research ongoing through the Severn Network linking to Major Trauma.
ELABS
Research Division: ASCR
General overview of study: A multi-centre randomised controlled trial of both the effectiveness and cost-effectiveness of the treatment of hypertrophic burn scars with Pulsed Dye Laser (PDL) and standard care compared to standard care alone.
Funded by: NIHR
Principal Investigator: Jonathan Pleat
Patient Group: Patients with ≥1% TBSA burn wound grafted or conservatively managed
For additional information: Please contact MTTraining@nbt.nhs.uk
COMITED
Research Division: Emergency Department
General overview of study: Conservative Management in Traumatic Pneumothoraces in the Emergency Department (CoMiTED). This is a Randomised Controlled Trial
Funded by: NIHR Health Technology Assessment Programme
Principal Investigator: Edd Carlton
Patient Group: Aged, or believed to be aged 16+ with Traumatic Pneumothoracies in whom the treating clinician(s) believed either chest drain or conservative management is a suitable treatment
For additional information: Please follow the link CoMiTED – Conservative Management in Traumatic Pneumothoraces in the Emergency Department (CoMiTED): A Randomised Controlled Trial (bristol.ac.uk)
SMTN Paediatric Nursing
Paediatric Major Trauma Competencies Study Day – Level 1 (Network)
This single day study event will provide an introduction to the following topics: Overview of Major Trauma networks, the influence of Human Factors on teamwork, ABCDE of Paediatric Major Trauma Care, Trauma skills stations &Trauma simulations. This is a chargeable course – approx. £50 per attendee.
Duration: 1 day
Target candidates: This event is aimed at nursing staff with minimal or no experience of Paediatric Major Trauma. Attendees will be working within an Emergency Department/ working in a different department who may be called to assist with a paediatric trauma.
For enquiries please contact: FacultyOfChildrensNurseEducation@UHBristol.nhs.uk
Paediatric Major Trauma Competencies Study Day – Advanced (Network)
This single day study event will build on your existing knowledge and prior experience of major trauma. Topics include: Advanced Airway Skills, Neuro-assessment/Spinal Shock, Bereavement and Organ Donation, Burns, Human Factors Elements of Senior Nurse Role &Trauma Simulations. This is a chargeable course – approx. £50 per attendee.
Duration: 1 day
Target candidates: This event is aimed at nursing staff with a minimum of 2 years emergency nursing experience. Attendees will be working within an Emergency Department/working in a different department who may be called to assist with a paediatric trauma.
For enquiries please contact: FacultyOfChildrensNurseEducation@UHBristol.nhs.uk
SMTN Nurse and AHP Training
Trauma Immediate Life Support (TILS)
The TILS study day encompasses lectures, workstations & Trauma moulages where all the skills learnt during the day are consolidated in simulation. The candidates are not expected to undertake skills or roles during the day that they don’t undertake in real life, the course helps standardise the care & treatment that each major trauma patient will receive regardless of day/ time of attendance.
Duration: 1 day, 6 times per year at MTC.
Target candidates: All nurses within the Emergency department will complete. New Band 5 nurses starting in the emergency department will be booked into the TILS study day within 6 months of starting their post. There will be a trial period of opening this course up to junior doctors in the Emergency department and wards. Each trauma unit should have their own TILS course implemented with resources provided by the MTC but network places can be made available to support units as required.
For enquiries please contact: EDEducationTeam@nbt.nhs.uk
Trauma Immediate Life Support (TILS) - Recert
To be completed approx. 2 years after TILS. Recap on Trauma skills with new workshops and simulations.
Duration: 1 day, 6 times per year at MTC.
Target candidates: All nursing bands that have completed TILS.
For enquiries please contact: EDEducationTeam@nbt.nhs.uk
Neuro Study Day Level 1
Neuro ward study day. Provides an overview of brain anatomy, seizure management, clinical skills including Glasgow Coma Scale assessment, log rolling and hard collar application. Spinal cord injury and autonomic dysreflexia. Brain haemorrhages, neuro psychology and neurogenic bowel and bladder, EVD/lumbar drain management and FVC.
Duration: 7.5 hours, run quarterly
Target candidates: Nurses from 6b, 7a, 25a, 34a, 34b
For enquiries please contact: Abigail.Lindsay@nbt.nhs.uk : Book on LEARN
Trauma and Musculoskeletal study day
Plan to develop a trauma course with an emphasis on musculoskeletal trauma, and wider areas of major trauma care including special circumstances, psychological aspects, deteriorating patients and chest drain care and management.
Duration: 7.5 hours, run bi-yearly
Target candidates: Nurses from 25a, 6b, ICU, 33a, open to other wards receiving trauma
For enquiries please contact: mttraining@nbt.nhs.uk
25A in situ SIM and clinical skills - Development of a Level 2 Emergency Department Severn Network Course
Adapted from the Musgrove Park hospital course. This is a comprehensive course mapped to the level 2 requirements in the NMTNG competencies. Would need to be PEER reviewed by the NMTNG once established and running.
Duration: 15 hours, run bi-yearly
Target candidates: Senior nurses and junior doctors in the Emergency Departments across the Severn Network.
For enquiries please contact: mttraining@nbt.nhs.uk
SMTN Medical Training
European Trauma Course
The European trauma course is an internationally recognised trauma course covering the initial assessment and management of a major trauma patient. It is certified by the European Resuscitation Council. The course is a mix of workshops and scenarios course which is reflective of the European (including UK) approach to trauma in the hospital setting. This is a chargeable course – approx. £750 per attendee.
Duration: 2 ½ days, twice per year
Target candidates: Aimed at nurses and doctors who will be involved in the initial management and assessment of a major trauma patient. Usually band 6 and above nurses, or doctors ST3 and higher.
For enquiries please contact: ResuscitationTraining@nbt.nhs.uk
Trauma Team Leader
This annual regional update for Severn Major Trauma Network trauma team leaders (TTL’s) is a mandatory course for TTL’s. Attendance on at least 1 day every 3 years is required to remain on the rota. It consists of a series of lectures and wet lab dissections that focuses on recent changes in trauma practice and surgical skills required for rare events. These events include (but not restricted to) resuscitative thoracotomy, lateral canthotomy, emergency amputation and surgical airways.
Duration: 1 day, once per year
Target candidates: Trauma Team Leaders and aspiring Trauma Team Leaders who will are eligible to join the consortium or emergency department trauma team leader rotas. (Substantive Consultants in post within the trauma network, who have sufficient credibility in managing major trauma patients.)
For enquiries please contact: mttraining@nbt.nhs.uk
Emergency Anaesthesia in Major Trauma
This is a half day simulation course, aimed at those providing anaesthesia cover on the 3rd on-call rota covering major trauma calls and ED nurses. The purpose of the course is to provide an evidenced-based, standardised approach to emergency anaesthesia for major trauma. It focuses on utilising our Standard Operating Procedure for rapid sequence induction in trauma.
It aims to consolidate the experiences of trauma anaesthesia candidates have and provide exposure to the common emergencies and guidelines associated with anaesthesia for Major Trauma in the MTC.
Duration: ½ day, 3-4 times per year.
Target candidates: Those who will be delivering or assisting in the delivery of anaesthesia to major trauma patients in the emergency department. This includes senior nurses, trauma team leaders and senior trainees (ST3+) and consultants in anaesthesia and critical care. Places open to the network.
For enquiries please contact: mttraining@nbt.nhs.uk
Chest Drain
This course is a combination of workstations, and lectures specifically related to surgical intercostal chest drains in the context of major trauma. It covers indications, complications, technique for insertion and ongoing management of the drains. The last section looks at the indications for referral and the bespoke traumatic chest injury pathway including access to specialist thoracic services.
Duration: ½ day, 3 times per year (MTC). 1 session planned at YDH.
Target candidates: Those who may be expected to insert chest drains in trauma i.e. ST3 and higher specialist trainees in orthopaedic surgery, general surgery, anaesthetics/ intensive care, and emergency medicine. Places open to the network.
For enquiries please contact: mttraining@nbt.nhs.uk
Scribe Education Sim
Introduction to the role of the scribe & in-depth look at the documentation required.
Duration: ½ day as required for MTC or TU’s in the Severn Major Trauma Network
Target candidates: Emergency Department Band 3’s. Places open to the network.
For enquiries please contact: EDEducationTeam@nbt.nhs.uk
F1 & F2 trust-wide teaching
We provide training to F1 and F2 doctors trust wide as part of their weekly training programme. We focus on the primary survey, the assessment of the Major Trauma patient and procedures including transfusion, splints and binders and reduction of fractures.
Duration: 1 day
Target candidates: F1 and F2 Doctors
Junior Doctor Induction
We visit departmental induction to explain the role of the Trauma Team and the staff members within it. We also include dates for planned study days and M&M meetings. Currently attend Medicine, General Surgery, Neurosurgery and Orthopaedic induction sessions. We can tailor this training to meet the needs of your staff.
If you would like us to attend your induction, or arrange a specific teaching session, please get in touch.
Duration: 1 day
Target candidates: Junior Doctors
Development of a level 2 Emergency department Severn Network course
Adapted from the Musgrove Park hospital course. This is a comprehensive course mapped to the level 2 requirements in the NMTNG competencies. Would need to be PEER reviewed by the NMTNG once established and running.
Duration: 15 hours, run bi-yearly
Target candidates: Senior nurses and junior doctors in the Emergency Departments across the Severn Network.
For enquiries please contact: mttraining@nbt.nhs.uk
Trauma Team Members – currently on hold
This is a simulation based course looking at technical and non-technical skills for all members of the major trauma team. The aim of the course is to create an environment in which to practice trauma team skills, promote team working and to discuss any aspects of trauma team management.
Duration: 1 day, twice per year
Target candidates: All staff who will be attending trauma calls in the emergency departments.
For enquiries please contact: mttraining@nbt.nhs.uk
SMTN Conferences
Joint Peninsula and Severn Stakeholder Day, 10am-3pm, Tuesday 6th of May 2025
Location – Health Innovation South West, Vantage Point, Pynes hill, Exeter, EX2 5FD
Any queries for the Severn Major Trauma Network, please contact: MTTraining@nbt.nhs.uk
Agenda
Time | Agenda Item |
---|---|
09:30 - 10:00 | Registration |
10:00 - 10:15 | Welcome - Dr Giles Haythornthwaite, pMTC Network Lead |
10:15 - 10:55 | WATCh Update and Future Directions - Dr Dora Wood, WATCh Clinical Lead |
10:55 - 11:15 | Challenging case from a Trauma Unit Perspective - Dr Fionna Lowe, UH Plymouth Governance Lead |
11:15 - 11:35 | Empowering Recovery: Enhancing Service Provision for Spinal Cord Injury - Amy Fraser, Paediatric Spinal Cord Injury Link Worker |
11:35 - 12:00 | Safeguarding in Focus: Latest Updates and Best Practices - Dr Will Christian, Consultant in Paediatric Emergency Medicine, Safeguarding Lead, Bristol |
12:00 - 12:45 | Lunch |
12:45 - 13:30 | Poly Trauma Case Study - Ms Flossie Carpenter, Paediatric T&O Reg Enhancing Paediatric Care: Service Provision at the pMTC - Miss Anna Clarke, Clinical Lead for Major Trauma |
13:30 - 13:50 | Psychosocial clinical network guideline: Streamlining Network Guidelines through a platform - Nicky Robinson, pMTC Nurse Coordinator |
13:50 - 14:10 | Coffee |
14:10 - 14:30 | Neurosurgical Time Critical Transfer Audit - Dr John Coveney, Specialist Registrar Paediatrics |
14:30 - 14:55 | From Classroom to Clinic: Enhancing Nursing Education TU Visits - Jess Harvey, pMTC Nurse Coordinator |
14:55 - 15:00 | Review and Close - Dr Giles Haythornthwaite, pMTC Network Lead |
Spinal Nursing Study Day, 08:30- 16:45 Tuesday 20th of May 2025
Registration link - Spinal Cord Injury Nursing Study Day Tickets, Tue 20 May 2025 at 08:30 | Eventbrite
Location - Salisbury & South Wilts Cricket Club, Wilton Road, Quidhampton SP2 9NY
Cost - £220
Time | Agenda Item |
---|---|
08:45 – 09:00 | Welcome, introductions, housekeeping and pre survey Spinal Education Lead Emma Gumbleton |
09:00 – 10:00 | Overview of spinal cord Injury Spinal Consultant Dr Gemma Simons |
10:00 – 10:30 | Spinal Outreach Services Acute Outreach and Admission Lead – Danilo Galila |
10:30 – 11:00 | Spasms and Spasticity Clinical Specialist Physiotherapist Racheal Coulson-Smith |
11:00 – 11:15 | Tea and coffee |
11:15 – 12:00 | Rehabilitation after spinal cord injury Clinical Specialist Physiotherapist Racheal Coulson-Smith |
12:00 – 12:30 | Management respiratory system Spinal Respiratory Nurse Specialist – Chelsie Hart |
12:30 – 13:00 | Autonomic Dysreflexia Spinal Education Lead – Emma Gumbleton |
13:00 – 13:30 | Lunch (provided) |
13:30 – 14:00 | Neurogenic Bowel Spinal Education Team – Harriet Evans |
14:00 – 14:30 | Neurogenic Bladder Spinal Education Team – Gemma Donaghy |
14:30 – 15:00 | Workshops – tea and coffee |
15:00 – 15:30 | Neurogenic Skin Spinal Education Lead – Emma Gumbleton |
15:30 – 16:00 | Psychological Support Lead Psychologist – Kath Gwynn |
16:00 – 16:30 | Spinal Outpatients Outpatient Lead/Clinical Nurse Specialist – Sen Peralta |
16:30 – 16:45 | Resources, questions and feedback |
National Major Trauma Rehabilitation Group, 9-10th of June
Dr Christina Giavasi - Neurology
GMC number: 7021866
Year & location of first qualification: 2006 University of Athens, Greece
Specialty: Neurology
Clinical interests: Epilepsy
Secretary: Stephanie Burke
Secretary phone number: 0117 4147718
Dr Ankur Gupta-Wright - General Internal Medicine
GMC number: 6163885
Year & location of first qualification: 2007 Imperial College London
Specialty: Infectious Diseases & General Internal Medicine
Clinical interests: Tuberculosis, HIV, Tropical Medicine
Secretary: Denise Bennett/Lynne Brown
Secretary phone number: 0117 4146479
Dr Ankur Gupta-Wright is a consultant in Infectious Diseases and General Internal Medicine, actively involved in patient care, teaching and research. Dr Ankur Gupta-Wright undertook clinical and academic training in Leicester, Singapore and London, and have worked in many settings including low and middle-income countries. Dr Ankur Gupta-Wright's clinical interest are management of tuberculosis (TB), including drug-resistant TB, HIV, HIV and TB co-infection, tropical medicine and general infectious diseases. Dr Ankur Gupta-Wright's research interests are in how we can use point of care diagnostics to improve clinical outcomes in patients with suspected infections. Dr Ankur Gupta-Wright undertook a PhD in urine-based diagnostics for TB. Dr Ankur Gupta-Wright has Diplomas in Tropical Medicine & Hygiene, HIV medicine and Medical Leadership. Dr Ankur Gupta-Wright is a fellow of Advance HE and hold a Post Graduate Certificate in Learning & Teaching.
Dr Laura Duerden - Clinical Radiology
GMC number: 71379790
Year & location of first qualification: 2011, Cardiff University
Specialty: Radiology
Clinical interests: Cardiothoracic imaging
Secretary: Alex Palmer
Telephone no: 01174149010